Metastasis is the primary cause of death from cancer. Current lack of medicines for metastasis makes it a topical issue and encourages the global search for molecules that may potentially inhibit invasiveness of cancer cells, and thus prevent metastatic spread. Drug repurposing is a strategy of identifying new uses for approved drugs that are outside the scope of the original medical indication. The aim of this thesis is to summarize knowledge on the repurposing potential of selected groups of drugs with emphasis on molecular mechanisms of their action. In particular, the work is focused on selected antipsychotics, antidepressants, beta- blockers and statins, whose abilities to inhibit cancer invasiveness have been indicated
Cancer is one of the leading causes of death worldwide. There are only limited treatment strategies ...
Worldwide, prostate cancer (PC) is the second most frequent cancer among men and the fifth leading c...
Drug repurposing is the process of finding new therapeutic applications for previously used, availab...
Most patients that die from cancer do not die due to the primary tumor but due to the development of...
The increasing unraveling of the molecular basis of cancer offers manifold novel options for interve...
In this thesis, the topic and applications of drug repurposing are explained. Drug repurposing is th...
The majority of prostate cancer (PCa) deaths occur due to the metastatic spread of tumor cells to di...
The substantial costs of clinical trials, the lengthy timelines of new drug discovery and developmen...
Metastatic disease is responsible for 90% of death from solid tumors. However, only a minority of me...
Cancer is among the leading causes of death worldwide. While some types of cancer became almost enti...
Drug repositioning is gaining increasing attention in drug discovery because it represents a smart w...
Regardless of the enormous investments in cancer research and drug development, the proportion of ap...
BACKGROUND: Drug repurposing, the application of known drugs and compounds with a non-oncology prima...
Drug repurposing is a strategy that aims to develop novel cancer treatments through the reuse of exi...
Drug repurposing is one of the best strategy for drug discovery. There are several examples where dr...
Cancer is one of the leading causes of death worldwide. There are only limited treatment strategies ...
Worldwide, prostate cancer (PC) is the second most frequent cancer among men and the fifth leading c...
Drug repurposing is the process of finding new therapeutic applications for previously used, availab...
Most patients that die from cancer do not die due to the primary tumor but due to the development of...
The increasing unraveling of the molecular basis of cancer offers manifold novel options for interve...
In this thesis, the topic and applications of drug repurposing are explained. Drug repurposing is th...
The majority of prostate cancer (PCa) deaths occur due to the metastatic spread of tumor cells to di...
The substantial costs of clinical trials, the lengthy timelines of new drug discovery and developmen...
Metastatic disease is responsible for 90% of death from solid tumors. However, only a minority of me...
Cancer is among the leading causes of death worldwide. While some types of cancer became almost enti...
Drug repositioning is gaining increasing attention in drug discovery because it represents a smart w...
Regardless of the enormous investments in cancer research and drug development, the proportion of ap...
BACKGROUND: Drug repurposing, the application of known drugs and compounds with a non-oncology prima...
Drug repurposing is a strategy that aims to develop novel cancer treatments through the reuse of exi...
Drug repurposing is one of the best strategy for drug discovery. There are several examples where dr...
Cancer is one of the leading causes of death worldwide. There are only limited treatment strategies ...
Worldwide, prostate cancer (PC) is the second most frequent cancer among men and the fifth leading c...
Drug repurposing is the process of finding new therapeutic applications for previously used, availab...